Sarah Davis

MPhys

School of Medicine and Population Health

Senior Research Fellow

Sarah Davis
Profile picture of Sarah Davis
s.davis@sheffield.ac.uk
+44 114 222 5209
+44 114 222 0749 (Fax)
Regent Court (ScHARR)

Full contact details

Sarah Davis
School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
Profile

I have over 15 years experience in developing health economic models to evaluate the cost-effectiveness of healthcare interventions including diagnostic tests, risk-assessment tools, and both pharmacological and non-pharmacological treatments. I work primarily on NICE technology appraisals and research projects funded by the NIHR HTA programme. I am a member of ScHARR-TAG and I was the Deputy Director of the NICE Decision Support Unit (DSU) from January 2010 to March 2022

I previously spent three years as the Senior Health Economist at the National Collaborating Centre for Nursing and Supportive Care which developed Clinical Guidelines for NICE. When this centre was merged with three others to form the National Clinical Guideline Centre (NCGC) in April 2009, I joined the NCGC as Health Economics Lead. Prior to this, I was a cost-effectiveness modeller within the HEDS section at ScHARR from 2004 to 2006.

Research interests

My research interests are cost-effectiveness modelling, technology appraisal, and clinical guideline development.

Current projects

  • The cost-effectiveness of venous thromboembolism risk assessment tools for hospital inpatients - NIHR127454
Publications

Show: Featured publications All publications

Journal articles

  • Davis S, Goodacre S, Pandor A, Horner D, Stevens JW, de Wit K & Hunt BJ (2019) . British Journal of Haematology, 186(1), 166-168.
  • van Baal P, Morton A, Brouwer W, Meltzer D & Davis S (2017) . BMJ, 359.
  • Franklin M, Davis S, Horspool M, Kua WS & Julious S (2017) . PharmacoEconomics, 35(5), 561-573.
  • Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al (2016) . Health Technology Assessment, 20(78), 1-406.
  • Ciani O, Cantrell A, Davis S, Tappenden P, Saad ED, Garside R, Buyse M, Stein K & Taylor RS (2014) . International Journal of Technology Assessment in Health Care, 30(3), 312-324.
  • Akunne A, Davis S, Westby M & Young J (2014) . Eur J Orthop Surg Traumatol, 24(2), 187-195.
  • Davis S & Wailoo A (2013) . Health Qual Life Outcomes, 11, 20.
  • Davis S, Westby M, Petkar S & Pitcher D (2013) . Heart, 99(11), 805-810.
  • Davis S, Westby M, Pitcher D & Petkar S (2012) . Europace, 14(3), 402-409.
  • Bansback N, Davis S & Brazier J (2007) . Eye (Lond), 21(12), 1455-1463.

All publications

Journal articles

  • Davis S, Mon-Yee M, Sutton A, Leaviss J, Forsyth JE & Burton C (2025) . Expert Review of Pharmacoeconomics & Outcomes Research.
  • Sampson FC, Davis S, Kuczawski M, Carser R, Hunt BJ, Goodacre S, Pandor A, Nelson-Piercy C & Daru J (2025) What influences women’s decisions to participate in trials for prevention of venous thromboembolism during pregnancy and the puerperium: a qualitative study. BMC pregnancy and childbirth, 25(1).
  • Briggs AH, Doyle-Connolly A, Schneider J, Podkonjak T, Taylor H, Roffe E, Low E, Davis S, Kaiser M, Hatswell AJ & Rabin N (2025) . Value in Health, 28(1), 72-80.
  • Horner DE, Davis S, Pandor A, Shulver H, Goodacre S, Hind D, Rex S, Gillett M, Bursnall M, Griffin X , Holland M et al (2024) . Health Technology Assessment, 28(20).
  • Sahota O, Narayanasamy M, Bastounis A, Paskins Z, Bishop S, Langley T, Gittoes N, Davis S, Baily A, Holmes M & Leonardi-Bee J (2024) . Health Technology Assessment, 28(21), 1-169.
  • Davis S, Pandor A, Sampson F, Hamilton J, Nelson-Piercy C, Beverley H, Jahnavi D, Goodacre S, Carser R, Rooney G & Clowes M (2024) . Health Technology Assessment, 28(9).
  • Davis S, Goodacre S, Horner D, Pandor A, Holland M, de Wit K, Hunt BJ & Griffin XL (2024) . BMJ Medicine, 3(1).
  • Khalid TY, Peters TJ, Pocock LV, Drew S, Hardcastle SA, Paskins Z, Davis S, Kariki EP & Clark EM (2024) . Archives of Osteoporosis, 19(1).
  • Guthrie B, Rogers G, Livingstone S, Morales D, Donnan P, Davis S, Youn JH, Hainsworth R, Thompson A & Payne K (2024) . Health and Social Care Delivery Research, 12(4).
  • Guthrie B, Rogers G, Livingstone S, Morales DR, Donnan P, Davis S, Youn JH, Hainsworth R, Thompson A & Payne K (2024) . Health and Social Care Delivery Research, 12(4).
  • Davis S, Pandor A, Sampson F, Hamilton J, Nelson-Piercy C, Hunt BJ, Daru J & Goodacre S (2024) . Journal of Thrombosis and Haemostasis, 22(4), 1105-1116.
  • Hunt B, Sampson F, Goodacre S, Pandor A, Nelson-Piercy C, Daru J, Carser R, Metry A & Davis S (2023) . Research and Practice in Thrombosis and Haemostasis, 7, 101939-101939.
  • Paskins Z, Moult A, Corp N, Bastounis A, Davis S, Narayanasamy MJ, Griffin J, Gittoes N, Leonardi-Bee J, Langley T , Bishop S et al (2023) . Osteoporosis International, 34(10), 1711-1718.
  • Davis S, Goodacre S, Horner D, Pandor A, Griffin XL, de Wit K, Hunt BJ & Holland M (2023) . Journal of Thrombosis and Haemostasis, 21(6), 1580-1591.
  • Pandor A, Daru J, Hunt BJ, Rooney G, Hamilton J, Clowes M, Goodacre S, Nelson-Piercy C & Davis S (2022) . BMJ Open, 12(10).
  • Bastounis A, Langley T, Davis S, Paskins Z, Gittoes N, Leonardi‐Bee J & Sahota O (2022) . JBMR Plus, 6(5).
  • Khera T, Hunt LP, Davis S, Gooberman-Hill R, Thom H, Xu Y, Paskins Z, Peters TJ, Tobias JH & Clark EM (2022) . Age and Ageing, 51(3).
  • Bastounis A, Langley T, Davis S, Paskins Z, Gittoes N, Leonardi-Bee J & Sahota O (2022) . Osteoporosis International, 33(6), 1223-1233.
  • Mattia L, Davis S, Mark-Wagstaff C, Abrahamsen B, Peel N, Eastell R & Schini M (2022) . Bone, 158.
  • Horner D, Goodacre S, Davis S, Burton N & Hunt BJ (2021) . BMJ: British Medical Journal, 373.
  • (2021) World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 32(Suppl 1), 119-410.
  • Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R & White P (2020) . Health Technology Assessment, 24(46), 1-490.
  • Davis S, Simpson E, Hamilton J, James MM-S, Rawdin A, Wong R, Goka E, Gittoes N & Selby P (2020) . Health Technology Assessment, 24(29), 1-314.
  • Simpson E, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P & Davis S (2020) . Bone, 130.
  • Pandor A, Horner D, Davis S, Goodacre S, Stevens JW, Clowes M, Hunt BJ, Nokes T, Keenan J & de Wit K (2019) . Health Technology Assessment, 23(63), 1-190.
  • Khera TK, Burston A, Davis S, Drew S, Gooberman-Hill R, Paskins Z, Peters TJ, Tobias JH & Clark EM (2019) . Archives of Osteoporosis, 14(1).
  • Horner D, Goodacre S, Pandor A, Nokes T, Keenan J, Hunt B, Davis S, Stevens JW & Hogg K (2019) . Emergency Medicine Journal, 1-6.
  • Davis S, Goodacre S, Pandor A, Horner D, Stevens JW, de Wit K & Hunt BJ (2019) . British Journal of Haematology, 186(1), 166-168.
  • Davis S, Rafia R, Carroll C, Hamilton J & Essat M (2019) . Pharmacoeconomics, 37, 763-775.
  • Rafia R, Pandor A, Davis S, Stevens JW, Harnan S, Clowes M, Sorour Y & Cutting R (2018) . Pharmacoeconomics, 36(10), 1143-1151.
  • Julious SA, Horspool MJ, Davis S, Franklin M, Smithson WH, Norman P, Simpson RM, Elphick H, Bortolami O & Cooper C (2018) . BMJ Open, 8(4).
  • van Baal P, Morton A, Brouwer W, Meltzer D & Davis S (2017) . BMJ, 359.
  • Möller J, Davis S, Stevenson M & Caro JJ (2017) . PharmacoEconomics, 35(10), 1103-1109.
  • Franklin M, Davis S, Horspool M, Kua WS & Julious S (2017) . PharmacoEconomics, 35(5), 561-573.
  • Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al (2016) . Health Technology Assessment, 20(78), 407-424.
  • Julious SA, Horspool MJ, Davis S, Bradburn M, Norman P, Shephard N, Cooper CL, Smithson WH, Boote J, Elphick H , Loban A et al (2016) . Health Technology Assessment, 20(93), 1-154.
  • Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al (2016) . Health Technology Assessment, 20(78), 1-406.
  • Sanderson J, Martyn-St James M, Stevens J, Goka E, Wong R, Campbell F, Selby P, Gittoes N & Davis S (2016) . Bone, 89, 52-58.
  • Simpson EL, Davis S, Thokala P, Breeze PR, Bryden P & Wong R (2015) . Pharmacoeconomics.
  • Campbell F, Holmes M, Everson-Hock E, Davis S, Woods HB, Anokye N, Tappenden P & Kaltenthaler E (2015) . Health Technology Assessment, 19(60).
  • Holmes M, Davis S & Simpson E (2015) . PharmacoEconomics, 33(3), 225-233.
  • Pennington B & Davis S (2014) . Value in Health, 17(8), 762-771.
  • Ciani O, Cantrell A, Davis S, Tappenden P, Saad ED, Garside R, Buyse M, Stein K & Taylor RS (2014) . International Journal of Technology Assessment in Health Care, 30(3), 312-324.
  • Akunne A, Davis S, Westby M & Young J (2014) . Eur J Orthop Surg Traumatol, 24(2), 187-195.
  • (2014) . Heart, 100(4), 350-350.
  • Horspool MJ, Julious SA, Boote J, Bradburn MJ, Cooper CL, Davis S, Elphick H, Norman P, Smithson WH & vanStaa T (2013) . Trials, 14(1).
  • Petkar S, Bullock I, Davis S & Cooper P (2013) . Heart.
  • Tosh J, Archer R, Davis S, Stevenson M & Stevens JW (2013) . Pharmacoeconomics, 31(8), 653-661.
  • Davis S & Wailoo A (2013) . Health Qual Life Outcomes, 11, 20.
  • Davis S, Westby M, Petkar S & Pitcher D (2013) . Heart, 99(11), 805-810.
  • Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P & Moxham T (2013) . Age Ageing, 42(1), 14-20.
  • Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A , Jeffreys M et al (2012) . Health Technol Assess, 16(21), 1-470.
  • Davis S, Westby M, Pitcher D & Petkar S (2012) . Europace, 14(3), 402-409.
  • Westby M, Bullock I, Cooper PN, Davis S & Guideline Dev Grp (2010) . BRIT MED J, 341.
  • Karnon J, Czoski-Murray C, Smith K, Brand C, Chakravarthy U, Davis S, Bansback N, Beverley C, Bird A, Harding S , Chisholm I et al (2008) . Health Technol Assess, 12(27), iii-124.
  • Ward S, Simpson E, Davis S, Hind D, Rees A & Wilkinson A (2007) . Health Technol Assess, 11(40), 1-144.
  • Kanis JA, Stevenson M, McCloskey EV, Davis S & Lloyd-Jones M (2007) Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.. Health technology assessment (Winchester, England), 11(7).
  • Kanis JA, Stevenson M, McCloskey EV, Davis S & Lloyd-Jones M (2007) . Health Technol Assess, 11(7), iii-231.
  • Stevenson M, Davis S, Lloyd-Jones M & Beverley C (2007) . Health Technol Assess, 11(4), 1-134.
  • Brennan A, Akehurst R, Davis S, Sakai H & Abbott V (2007) . Value Health, 10(1), 32-41.
  • Bansback N, Davis S & Brazier J (2007) . Eye (Lond), 21(12), 1455-1463.
  • Stevenson M, Davis S & Kanis J (2006) . Women S Health Medicine, 3(4), 149-151.
  • Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S & Oakley J (2005) . Health Technol Assess, 9(22), 1-160.
  • Chilcott J, Bessey A, Bonham JR, Castilla-Rodriguez I, Davis S, Elliman D, Hunt S, Hyde C, Lombardo S, Madan J , Marshall J et al () Methodological and procedural considerations for developing decision analytic models to assess the health economic impacts of newborn bloodspot screening: A systematic methodological review. International Journal of Neonatal Screening.

Conference proceedings

  • Paskins Z, Moult A, Corp N, Bastounis A, Davis S, Narayanasamy MJ, Griffin J, Gittoes N, Leonardi-Bee J, Langley T , Bishop S et al (2023) . RHEUMATOLOGY, Vol. 62(Supplement 2). Manchester, England, 24 April 2023 - 24 April 2023.
  • Davis S, Pandor A, Sampson F, Nelson-Piercy C, Hunt B & Daru J (2023) . BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 130(S1) (pp 20-20). Birmingham, United Kingdom
  • Mattia L, Mark-Wagstaff C, Abrahamsen B, Davis S, Peel N, Eastell R & Schini M (2022) Monitoring Bisphosphonate Treatment In Primary Care: PINP And Osteoporosis In Sheffield Evaluation (POSE Study). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 64-65)
  • Clark E, Khera T, Hunt L, Gooberman-Hill R, Paskins Z, Peters T, Tobias J & Davis S (2022) Addition of symptoms to traditional risk factors improves prediction of those at high risk of vertebral fractures: Results of the Vfrac study. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 37 (pp 60-60)
  • Bastounis A, Langley T, Davis S, Paskins Z, Gittoes N, Leonardi-Bee J & Sahota O (2021) . Osteoporosis International, Vol. 32(Suppl 1) (pp S270-S270). London, United Kingdom, 26 August 2021 - 26 August 2021.
  • Mattia L, Mark-Wagstaff C, Abrahamsen B, Davis S, Peel N, Eastell R & Schini M (2021) MONITORING BISPHOSPHONATE TREATMENT IN PRIMARY CARE: PINP AND OSTEOPOROSIS IN SHEFFIELD EVALUATION (POSE STUDY). OSTEOPOROSIS INTERNATIONAL, Vol. 32(SUPPL 1) (pp S288-S288)
  • Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad E, Buyse M & Taylor R (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A327-A327)
  • Brennan A, Wilson R, Davis S, Brandtmuller A & Akehurst R (2007) Economic evaluation of the use of lanthanum carbonate from an Australian perspective. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 22 (pp 186-186)
  • Brennan A, Akehurst R, Davis S & Sakai H (2004) Lanthanum carbonate for the treatment of hyperphosphataemia: Development of a cost effectiveness model. VALUE HEALTH, Vol. 7(6) (pp 805-805)

Reports

  • Kua WS & Davis S (2016) Systematic review of health state utilities in children with asthma

Preprints

  • Yee MM, Burton C, Leaviss J, Forsyth JE, Daly G & Davis S (2025) , Cold Spring Harbor Laboratory.
  • Leaviss J, Booth A, Coyle D, Daly G, Davis S, Dawes H, Deary V, Dwivedi K, Forsyth J, Fryer K , McCormick S et al (2025) , Cold Spring Harbor Laboratory.
  • Sampson FC, Davis S, Kuczawski M, Carser R, Hunt BJ, Goodacre S, Pandor A, Nelson-Piercy C & Daru J (2024) , Springer Science and Business Media LLC.
Teaching interests

My teaching interests include decision modelling in health care and supporting non-health economists to engage with health economic evidence when developing guidance for the NHS.

Professional activities and memberships

Member of NICE Highly Specialised Technologies Evaluation Committee

Links